• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-obesity medication patients' self-reported food savings versus the cost of such medicines.

作者信息

Roe Brian E

机构信息

Department of Agricultural, Environmental and Development Economics, Ohio State University, 2120 Fyffe Road, Columbus, OH, 43210, USA.

出版信息

Int J Obes (Lond). 2025 Mar;49(3):532-535. doi: 10.1038/s41366-024-01708-y. Epub 2024 Dec 29.

DOI:10.1038/s41366-024-01708-y
PMID:39738491
Abstract
摘要

相似文献

1
Anti-obesity medication patients' self-reported food savings versus the cost of such medicines.抗肥胖药物治疗患者自我报告的食物节省情况与此类药物成本的对比。
Int J Obes (Lond). 2025 Mar;49(3):532-535. doi: 10.1038/s41366-024-01708-y. Epub 2024 Dec 29.
2
Turning waste medicines to cost savings: A pilot study on the feasibility of medication recycling as a solution to drug wastage.变废药为成本节约：一项关于药品回收作为解决药物浪费问题可行性的试点研究。
Palliat Med. 2017 Jan;31(1):35-41. doi: 10.1177/0269216316639798. Epub 2016 Jul 18.
3
Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists.全科药师开展以患者为中心的药物治疗管理的成本效益分析。
Int J Clin Pharm. 2024 Aug;46(4):957-965. doi: 10.1007/s11096-024-01732-y. Epub 2024 May 30.
4
The Potential Cost-Effectiveness and Equity Impacts of Restricting Television Advertising of Unhealthy Food and Beverages to Australian Children.限制澳大利亚儿童观看不健康食品和饮料电视广告的潜在成本效益和公平性影响。
Nutrients. 2018 May 15;10(5):622. doi: 10.3390/nu10050622.
5
Cost savings from medication reviews in community pharmacies for nursing home residents in Estonia: a case study.社区药房对爱沙尼亚养老院居民进行药物审查的成本节约：案例研究。
BMC Health Serv Res. 2024 Sep 27;24(1):1119. doi: 10.1186/s12913-024-11504-z.
6
Comparing the cost, glycaemic control and medication adherence of utilizing patients' own medicines (POMs) versus usual dispensing among diabetic patients in an outpatient setting.比较门诊环境中使用患者自有药物（POM）与常规配药在成本、血糖控制和药物依从性方面的差异。
Daru. 2021 Jun;29(1):125-132. doi: 10.1007/s40199-021-00389-6. Epub 2021 Feb 4.
7
Impact of a clinical pharmacist-led, artificial intelligence-supported medication adherence program on medication adherence performance, chronic disease control measures, and cost savings.临床药师主导、人工智能支持的药物依从性项目对药物依从性表现、慢性病控制措施及成本节约的影响。
J Am Pharm Assoc (2003). 2025 Jan-Feb;65(1):102271. doi: 10.1016/j.japh.2024.102271. Epub 2024 Oct 18.
8
Longitudinal changes in self-reported medication adherence and beliefs about post-stroke medicines in Sweden: a repeated cross-sectional study.瑞典患者报告的卒中后药物治疗依从性和信念的纵向变化：一项重复横断面研究。
BMJ Open. 2024 Oct 18;14(10):e084680. doi: 10.1136/bmjopen-2024-084680.
9
Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care Setting.经济效用：基层医疗环境中用于精神卫生保健的组合药物基因组学与药物成本节约
Clin Ther. 2017 Mar;39(3):592-602.e1. doi: 10.1016/j.clinthera.2017.01.022. Epub 2017 Feb 21.
10
Affordability of medicines and patients' cost-reducing behaviour: empirical evidence based on SUR estimates from Italy and the UK.药品可负担性与患者降低成本行为：基于意大利和英国SUR估计的实证证据
Appl Health Econ Health Policy. 2005;4(1):23-35. doi: 10.2165/00148365-200504010-00005.

本文引用的文献

1
State Coverage and Reimbursement of Antiobesity Medications in Medicaid.医疗补助计划中抗肥胖药物的州覆盖范围及报销情况
JAMA. 2024 Apr 9;331(14):1230-1232. doi: 10.1001/jama.2024.3073.
2
Evaluating the Efficacy and Pharmacoeconomics of Semaglutide and Tirzepatide in the Setting of Obesity.评估司美格鲁肽和替西帕肽在肥胖治疗中的疗效和药物经济学。
Am J Ther. 2023;30(4):e347-e352. doi: 10.1097/MJT.0000000000001643.
3
Shifting paradigms: Reframing coverage of antiobesity medications for plan sponsors.转变范式：为计划赞助商重新构建抗肥胖药物的覆盖范围。
J Manag Care Spec Pharm. 2023 May;29(5):564-568. doi: 10.18553/jmcp.2023.29.5.564.
4
Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes.替尔泊肽可降低 2 型糖尿病患者的食欲、能量摄入和脂肪量。
Diabetes Care. 2023 May 1;46(5):998-1004. doi: 10.2337/dc22-1710.
5
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.持续每周皮下注射司美格鲁肽与安慰剂对超重或肥胖成年人体重维持的影响：STEP 4 随机临床试验。
JAMA. 2021 Apr 13;325(14):1414-1425. doi: 10.1001/jama.2021.3224.
6
Direct medical costs of obesity in the United States and the most populous states.美国和人口最多的州的肥胖直接医疗成本。
J Manag Care Spec Pharm. 2021 Mar;27(3):354-366. doi: 10.18553/jmcp.2021.20410. Epub 2021 Jan 20.
7
The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity.每周一次给予司美格鲁肽 2.4mg 对肥胖成年人的能量摄入、食欲、摄食控制和胃排空的影响。
Diabetes Obes Metab. 2021 Mar;23(3):754-762. doi: 10.1111/dom.14280. Epub 2021 Jan 3.
8
Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity.每周一次司美格鲁肽对肥胖受试者的食欲、能量摄入、摄食控制、食物偏好和体重的影响。
Diabetes Obes Metab. 2017 Sep;19(9):1242-1251. doi: 10.1111/dom.12932. Epub 2017 May 5.
9
The economic burden of obesity worldwide: a systematic review of the direct costs of obesity.全球肥胖的经济负担：肥胖直接成本的系统评价。
Obes Rev. 2011 Feb;12(2):131-41. doi: 10.1111/j.1467-789X.2009.00712.x.
10
Indirect costs of obesity: a review of the current literature.肥胖的间接成本：当前文献综述
Obes Rev. 2008 Sep;9(5):489-500. doi: 10.1111/j.1467-789X.2008.00472.x. Epub 2008 Mar 5.